CCP
HCA icon

Corient Capital Partners’s HCA Healthcare HCA Stock Holding History

Corient Capital Partners’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.11M Buy
6,625
+462
+7% +$92K 0.08% 202
2022
Q2 		$1.03M Sell
6,163
-993
-14% -$213K 0.08% 220
2022
Q1 		$1.79M Buy
7,156
+1,009
+16% +$253K 0.12% 157
2021
Q4 		$1.58M Buy
6,147
+28
+0.5% +$6.85K 0.1% 173
2021
Q3 		$1.49M Sell
6,119
-391
-6% -$95.6K 0.11% 174
2021
Q2 		$1.35M Buy
6,510
+311
+5% +$63.4K 0.1% 184
2021
Q1 		$1.17M Buy
6,199
+398
+7% +$70.2K 0.1% 183
2020
Q4 		$954K Buy
5,801
+204
+4% +$29.8K 0.1% 186
2020
Q3 		$698K Buy
5,597
+96
+2% +$11.9K 0.08% 211
2020
Q2 		$534K Buy
5,501
+29
+0.5% +$3.02K 0.07% 239
2020
Q1 		$492K Sell
5,472
-7,440
-58% -$963K 0.08% 218
2019
Q4 		$1.91M Sell
12,912
-1,113
-8% -$149K 0.24% 92
2019
Q3 		$1.69M Sell
14,025
-2,492
-15% -$322K 0.24% 96
2019
Q2 		$2.23M Sell
16,517
-887
-5% -$112K 0.34% 66
2019
Q1 		$2.27M Sell
17,404
-3,606
-17% -$484K 0.37% 66
2018
Q4 		$2.62M Sell
21,010
-9,128
-30% -$1.23M 0.47% 43
2018
Q3 		$4.19M Hold
30,138
– – 0.7% 25
2018
Q2 		$3.09M Sell
30,138
-156
-0.5% -$15.8K 0.54% 40
2018
Q1 		$2.94M Sell
30,294
-2,478
-8% -$240K 0.54% 42
2017
Q4 		$2.88M Buy
32,772
+1,967
+6% +$158K 0.49% 61
2017
Q3 		$2.45M Sell
30,805
-184
-0.6% -$14.8K 0.46% 60
2017
Q2 		$2.7M Sell
30,989
-1,439
-4% -$122K 0.41% 64
2017
Q1 		$2.89M Buy
32,428
+887
+3% +$74K 0.45% 51
2016
Q4 		$2.33M Buy
31,541
+8,456
+37% +$633K 0.41% 62
2016
Q3 		$1.75M Buy
+23,085
New +$1.77M 0.32% 84

Other funds holding HCA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Corient Capital Partners's HCA Position: Q3 2022 in Review

Corient Capital Partners increased its HCA Healthcare (HCA) stake by 7.5% in Q3 2022, buying an estimated $92K and bringing the position to 6,625 shares worth $1.11M. The position accounts for 0.08% of the portfolio, ranked #202.

Corient Capital Partners first reported a position in HCA in Q3 2016 and has held it in 25 quarters since. The position peaked at $4.19M in Q3 2018. 868 funds tracked by Wall St. Rank hold HCA as of Q3 2022.

  • Corient Capital Partners held 6,625 shares of HCA Healthcare worth $1.11M as of Q3 2022.
  • Corient Capital Partners bought 462 HCA Healthcare shares in Q3 2022, an estimated $92K.
  • HCA Healthcare made up 0.08% of Corient Capital Partners's portfolio in Q3 2022, its #202 holding.
  • Corient Capital Partners first reported a position in HCA Healthcare in Q3 2016 and has held it in 25 quarters since.
  • Corient Capital Partners's HCA Healthcare position peaked at $4.19M in Q3 2018.
  • 868 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.